Trial Profile
Phase I study of a second monoclonal antibody (n-CoDeR).
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 17 Sep 2014
Price :
$35
*
At a glance
- Drugs Monoclonal antibodies (Primary)
- Indications Unspecified
- Focus Adverse reactions
- Sponsors Bayer
- 17 Sep 2014 New trial record